Rongqing, Y., Jianjun, B., Qianshan, W. et al. Clinical and experimental study on treatment of chronic hepatitis B with Yanggan Aoping Mixture., CJIM 5, 20–24 (1999). https://doi.org/10.1007/BF02934183
Yu Rongqing, Bi Jianjun, Wang Qianshan, et al. Clinical and experimental study on treatment of chronic hepatitis B with Yanggan Aoping Mixture. [J]. Chinese Journal of Integrative Medicine 5(1):20-24(1999)
Rongqing, Y., Jianjun, B., Qianshan, W. et al. Clinical and experimental study on treatment of chronic hepatitis B with Yanggan Aoping Mixture., CJIM 5, 20–24 (1999). https://doi.org/10.1007/BF02934183DOI:
Yu Rongqing, Bi Jianjun, Wang Qianshan, et al. Clinical and experimental study on treatment of chronic hepatitis B with Yanggan Aoping Mixture. [J]. Chinese Journal of Integrative Medicine 5(1):20-24(1999) DOI: 10.1007/BF02934183.
Clinical and experimental study on treatment of chronic hepatitis B with Yanggan Aoping Mixture
摘要
Objective: To assess the efficacy of Yanggan Aoping Mixture (
YGAPM) in treating hepatitis B.Methods: Patients suffered from chronic hepatitis B were treated with YGAPM. Observe their short- and long-term efficacy and the change of serum hepatitis B virus marker. In experiment
the effects of YGAPM in treating rat’s liver injury as well as HBV-infected tree shrew and duck HBV-infected ducks were observed.Results: In 79 cases of chronic persistent hepatitis
the markedly effective rate was 60.76%
and further raised to 70.00% in follow-up study in 40 cases. In 73 cases of chronic active hepatitis
the markedly effective rate was 60.27%
and further raised to 62.50% in 32 follow-up cases. In the treatment group
85 of the 119 cases (71.43%) with HBeAg-positive were converted to negative. Whereas in the control group
only 40 of 89 HBeAg-positive cases (44. 94%) were converted to negative
P < 0. 01. Results of experimental study showed that negative conversion rate of tree shrew infected with HBV marker was raised
while the duck HBV DNA in infected duck blood was inhibited. Those compared with the control group separately
the difference was markedly significant.Conclusion: YGAPM is an effective drug in treating chronic hepatitis B
and it could effectively convert the marker to negative.
Abstract
Objective: To assess the efficacy of Yanggan Aoping Mixture (
YGAPM) in treating hepatitis B.Methods: Patients suffered from chronic hepatitis B were treated with YGAPM. Observe their short- and long-term efficacy and the change of serum hepatitis B virus marker. In experiment
the effects of YGAPM in treating rat’s liver injury as well as HBV-infected tree shrew and duck HBV-infected ducks were observed.Results: In 79 cases of chronic persistent hepatitis
the markedly effective rate was 60.76%
and further raised to 70.00% in follow-up study in 40 cases. In 73 cases of chronic active hepatitis
the markedly effective rate was 60.27%
and further raised to 62.50% in 32 follow-up cases. In the treatment group
85 of the 119 cases (71.43%) with HBeAg-positive were converted to negative. Whereas in the control group
only 40 of 89 HBeAg-positive cases (44. 94%) were converted to negative
P < 0. 01. Results of experimental study showed that negative conversion rate of tree shrew infected with HBV marker was raised
while the duck HBV DNA in infected duck blood was inhibited. Those compared with the control group separately
the difference was markedly significant.Conclusion: YGAPM is an effective drug in treating chronic hepatitis B
and it could effectively convert the marker to negative.
关键词
chronic hepatitis BYanggan Aoping Mixturehepatitis B virus infected tree shrewduck hepatitis B virus infected duck
Keywords
chronic hepatitis BYanggan Aoping Mixturehepatitis B virus infected tree shrewduck hepatitis B virus infected duck
references
1991; 30(1): 8–16.
1992; 33(5): 295–296.
1992; 33(6): 373.
1983: 4(1): 15–19.
1990; (3): 167–169.
1992; 8(4): 171–173.
LAK 1991; 30(1): 27–28.
1 1993: 34(11): 673–675.
Anna EL, Lars L, Anders N, et al. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5(4): 634–642.
Chinese medicine for treatment of chronic hepatitis B
Relationship of anxiety state with lymphocyte subsets and the effect of chinese medical treatment on anxiety in patients with chronic hepatitis B
Evaluation on quality of life and analysis on its correlation with TCM syndromes in patients of chronic hepatitis B
Influence of TCM therapy for supplementing Pi (脾) and nourishing Shen (肾) on dendritic cell function in patients with chronic hepatitis B treated by lamivudine
Two-year observation of the clinical efficacy in treating chronic hepatitis B patients with Ganxian recipe and lamivudine
Related Author
No data
Related Institution
Carolinas Medical Center
The Seventh People’s Hospital of Hangzhou City
Zhejiang Chinese Medical University
Department of Hepatopathy, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Department of Hepatopathy, Zhejiang Hospital of Integrated Traditional and Western Medicine